MEG
BIIB icon

Millstone Evans Group’s Biogen BIIB Stock Holding History

Millstone Evans Group’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.8K Hold
50
– – 0.01% 582
2026
Q1 		$9.17K Hold
50
– – 0.01% 579
2025
Q4 		$8.8K Hold
50
– – 0.01% 564
2025
Q3 		$7K Hold
50
– – ﹤0.01% 579
2025
Q2 		$6.28K Hold
50
– – ﹤0.01% 572
2025
Q1 		$6.84K Hold
50
– – ﹤0.01% 567
2024
Q4 		$7.65K Buy
+50
New +$8.43K 0.01% 524

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Amundi
Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Millstone Evans Group's BIIB Position: Q2 2026 in Review

Millstone Evans Group held its Biogen (BIIB) position steady in Q2 2026 at 50 shares worth $10.8K. The position accounts for 0.01% of the portfolio, ranked #582.

Millstone Evans Group first reported a position in BIIB in Q4 2024 and has held it in 7 quarters since. 842 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Millstone Evans Group held 50 shares of Biogen worth $10.8K as of Q2 2026.
  • Millstone Evans Group left its Biogen share count unchanged in Q2 2026.
  • Biogen made up 0.01% of Millstone Evans Group's portfolio in Q2 2026, its #582 holding.
  • Millstone Evans Group first reported a position in Biogen in Q4 2024 and has held it in 7 quarters since.
  • 842 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Millstone Evans Group's 13F filing for Q2 2026, filed 11 Aug 2026.